Sanavia Oncology Inc.
Server Ertem is a seasoned professional in the field of oncology and cancer research, currently serving as the Chief Executive Officer at Sanavia Oncology Inc. since February 2021. Prior experience includes involvement in the Runway Startup Program as an Entrepreneur at Cornell Tech from September 2019 to February 2021 and a role as a Postdoctoral Research Fellow at Memorial Sloan Kettering Cancer Center from January 2009 to September 2013. Server Ertem holds a Doctor of Philosophy (PhD) in Oncology and Cancer Biology from Weill Cornell Graduate School of Medical Sciences, completed between September 2003 and January 2009.
This person is not in any teams
This person is not in any offices
Sanavia Oncology Inc.
We are a New York-based biotech company with a team of drug developers from Memorial Sloan-Kettering Cancer Center, Rockefeller University, Weill Cornell Medicine and Columbia University. Majority of cancer patients do not benefit from currently available therapies due to drug resistance. We are developing novel immunotherapies that can safely and effectively overcome that drug resistance and improve patients' lives. We use our proprietary platform to discover clinically relevant, cancer-specific epitopes in different types of drug resistant tumors and to generate antibodies with atomic-level specificity to these epitopes. We combine high throughput sequencing, single-molecule super-resolution microscopy, 3D protein modeling and artificial intelligence with novel in vivo models for validating our targets and developing next generation immunotherapies that can safely and effectively eliminate drug-resistant tumors.